Business
PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - PreveCeutical Medical Inc.&#x...
About this update from Preveceutical Medical Inc
[{"type":"text","content":"PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical DevelopmentVancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the \"Company\" or \"PreveCeutical\"), is pleased to announce that on February 1, 2023, PreveCeutical has appointed ICON as the clinical research organization (CRO) to complete the following.Conduct a comprehensive gap analysis to both confirm current conclusions as well as identify any potential additional nonclinical studies (beyond those already underway or in the planning stage) that will be needed to support a successful initial IND and / or CTA submission.Construction of a clinical development plan for Phase 1 through pivotal Phase 3 studies.Authoring of the Investigational Brochure for the Client's lead peptide in the final indication of interest.Perform all three clinical trials.PreveCeutical shall commence the clinical development with ICON in Q1 2023 and work with regulators to seek any potential fast track provisions as we believe that a non-addictive pain analgesic will meet the requirements due to the global abuse of painkillers currently available.PreveCeutical's Chief Executive Officer, Mr. Stephen Van Deventer, commented, \"Moving forward as PreveCeutical transitions from an R&D company into clinical development, it is our priority to select the best partner for this development. After many reviews of the best global CROs, we have selected ICON as we believe that they are one of the best in the world, with experience in all clinical matters and, more importantly, pain treatment therapies. ICON provides us with the ability to be flexible in which countries we will perform the clinical work as they are established to perform these worldwide.\"ICON plc is a world-leading healthcare intelligence and clinical research organization. It provides outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. ICON employs approximately 41,150 in over 50 countries. About PreveCeuticalPreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products. The Company aims to be a leader in preventive health sciences sector. With the completion of three of its re...